Description
Is it possible to predict who may never need treatment for B-CLL?
Article: Is it possible to predict who may never need treatment for B-CLL?
€2.42
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: INTRODUCTION
€2.42 Add to cart -
Article: Highlights in digestive oncology
€2.42 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€147.15 Add to cart
